The BIO International Convention Enters its Final Day of “Breakthrough” Programming
Day four will feature the annual Scientific American WorldVIEW of the
global biotechnology industry
SAN DIEGO–(BUSINESS WIRE)–The 2017 BIO International Convention (BIO 2017), the world’s largest
gathering of the biotechnology industry, entered the fourth and final
day of compelling, immersive programming united under the theme of
“Breakthrough.” Hosted by the Biotechnology Innovation Organization
(BIO), BIO 2017 has been running this week at the San Diego Convention
Center.
The final day of BIO 2017 will include annual Scientific American
WorldVIEW of the global biotechnology industry and a special program
session focused on San Diego veterans who have made the transition into
the life sciences world.
Thursday, June 22 Highlights Include:
-
Business Development & Finance: Inside
the Minds of the Next Generation of Life Science VCs
Billions
of dollars of investment capital flowing into emerging biotech
startups, and there’s much at stake. This panel of young, tech savvy
venture capitalists will share how they view opportunities, the gaps
they see in today’s healthcare market, and the solutions they’re eager
to fund.
9:00 – 10:00 a.m. | Room 8, Upper Level
-
Digital Health: Digital
Health’s Rocky Road: Business Plans that Work
In this
panel, digital health leaders will share the challenges and lessons
learned from collaborating with pharmaceutical companies. They will
address questions including: What will allow companies to succeed and
thrive in this nascent industry? Will it be collaborations with pharma
partners? Or mastering the health insurance system? Or pursuing
self-insurance programs?
10:15 – 11:15 a.m. | Room 6EF, Upper
Level
-
Personalized Medicine & Diagnostics: The
Whole Picture: Consideration of Personalized Medicine in Value
Assessment Frameworks
Value assessment frameworks are
a relatively new concept in healthcare, designed to help providers and
patients choose treatments and guide reimbursement decisions. It is
not yet clear how these frameworks apply to personalized medicines.
Biopharma leaders will examine the current challenges associated with
value assessment frameworks, and how they can evolve to account for
personalized therapies and diagnostics.
10:15 – 11:15 a.m. |
Room 6D, Upper Level
-
Digital Health: Detect,
Predict, Prevent: Using Digital Technologies to Tackle Brain Disorders
Join
researchers from leading academic institutions, patient advocacy
organizations and biopharma innovators who will discuss how data
generated from smartphones and wearables can help predict and even
prevent brain disorders, such as depression, multiple sclerosis and
epilepsy. Panelists will address pressing questions such as:
How can we ensure the quality of the data generated? How can the data
gathered help identify endpoints for clinical studies? And most
importantly, how can we best capture those breakthroughs that have the
potential to improve patients’ lives?
11:30 a.m. – 12:45 p.m.
| Room 7A, Upper Level
-
Special Program: Veterans
Career Roundtable: From Service to Life Science
San
Diego veterans will discuss how they made successful transitions from
careers in service to careers in life science and what resources
fellow veterans need to prepare for impactful and meaningful
employment in the biotech industry. Learn about the many valuable
resources that are locally available for vets and how to get the most
out of the BIO Talent Connect event, immediately following.
1:00
– 2:00 p.m. | Spotlight Theatre: Sails Pavilion
-
Super Session: The
Scientific American WorldVIEW Super Session: Wrapping Up and Looking
Forward
Join Scientific American WorldVIEW and Nature
Biotechnology for a discussion around the multiplicity of issues
explored during the week’s programs and get a snapshot of future
trends. Key industry thought leaders will tackle the latest
commercial, scientific and ethical issues facing innovation
stakeholders today, and provide us with their views of the year ahead.
Co-hosted by Scientific American and Nature Biotechnology, and
moderated by Andrew Marshall, Chief Editor, Nature Biotechnology, this
Super Session, now in its 9th year, will examine global life science
innovation in unique and dynamic new ways.
1:00 – 2:30 p.m. |
Room 6A, Upper Level
Follow the 2017 Convention @BIOConvention,
and join the conversation and @IAmBIOtech.
The BIO International Convention is the largest global event for the
biotechnology industry and attracts the biggest names in biotech, offers
key networking and partnering opportunities, and provides insights and
inspiration on major trends affecting the industry. The Convention will
highlight the latest trends and the newest opportunities for executives,
investors, scientists, policy leaders, and media from around the world.
Speakers at the sessions will share breakthroughs in medicine,
diagnostics, the environment, energy production, business operations,
financing, partnerships, policy issues and food and agriculture. Visit http://convention.bio.org/
for the most up-to-date program and speaker information.
About BIO
BIO is the world’s largest trade association representing biotechnology
companies, academic institutions, state biotechnology centers and
related organizations across the United States and in more than 30 other
nations. BIO members are involved in the research and development of
innovative healthcare, agricultural, industrial and environmental
biotechnology products. BIO also produces the BIO
International Convention, the world’s largest gathering of the
biotechnology industry, along with industry-leading investor and
partnering meetings held around the world. BIOtechNOW is
BIO’s blog chronicling “innovations transforming our world” and the BIO
Newsletter is the organization’s bi-weekly email newsletter. Subscribe
to the BIO Newsletter.
Upcoming BIO Events
BIO World Congress
on Industrial Biotechnology
Montréal,
Canada
July 23-26, 2017
BIO Patient and Health
Advocacy Summit
The
Mayflower Hotel, Washington, DC
October 2-3, 2017
BIO Investor Forum
San Francisco
October 17-18, 2017
Contacts
Biotechnology Innovation Organization (BIO)
Theresa
Brady, 202-997-9034
Web: www.bio.org
Blog:
www.biotech-now.org
Twitter:
@IAmBiotech